Moberg Pharma (Balmex) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 2

Moberg Pharma (Balmex) General Information

Description

An anti-rash cream and ointment brand created to protect babies from harmful diaper rashes. The asset includes a portfolio of anti-rash creams for babies and an adult line for soothing skin irritations, enabling its clients to stay away from skin irritations.

Contact Information

Website
www.balmex.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 7 East Frederick Place
  • Suite 100
  • Cedar Knolls, NJ 07927
  • United States
Primary Industry
Personal Products
Acquirer
CrossingWell Consumer Health
Corporate Office
  • 7 East Frederick Place
  • Suite 100
  • Cedar Knolls, NJ 07927
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Moberg Pharma (Balmex) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Moberg Pharma (Balmex)‘s full profile, request access.

Request a free trial

Moberg Pharma (Balmex) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Moberg Pharma (Balmex)‘s full profile, request access.

Request a free trial

Moberg Pharma (Balmex) FAQs

  • Where is Moberg Pharma (Balmex) headquartered?

    Moberg Pharma (Balmex) is headquartered in Cedar Knolls, NJ.

  • What industry is Moberg Pharma (Balmex) in?

    Moberg Pharma (Balmex)’s primary industry is Personal Products.

  • Is Moberg Pharma (Balmex) a private or public company?

    Moberg Pharma (Balmex) is a Private company.

  • What is the current valuation of Moberg Pharma (Balmex)?

    The current valuation of Moberg Pharma (Balmex) is .

  • What is Moberg Pharma (Balmex)’s current revenue?

    The current revenue for Moberg Pharma (Balmex) is .

  • Who are Moberg Pharma (Balmex)’s investors?

    Chattem and Moberg Pharma have invested in Moberg Pharma (Balmex).

  • When was Moberg Pharma (Balmex) acquired?

    Moberg Pharma (Balmex) was acquired on 27-Apr-2018.

  • Who acquired Moberg Pharma (Balmex)?

    Moberg Pharma (Balmex) was acquired by CrossingWell Consumer Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »